BACKGROUND: Fluid-attenuated inversion recovery (FLAIR) hyperintensity within an acute cerebral infarct may reflect delayed onset time and increased risk of hemorrhage after thrombolysis. Given the important implications for clinical practice, we examined the prevalence of FLAIR hyperintensity in patients 3-6 h from stroke onset and its relationship to parenchymal hematoma (PH). METHODS: Baseline DWI and FLAIR imaging with subsequent hemorrhage detection (ECASS criteria) were prospectively obtained in patients 3-6 h after stroke onset from the pooled EPITHET and DEFUSE trials. FLAIR hyperintensity within the region of the acute DWI lesion was rated qualitatively (dichotomized as visually obvious or subtle (i.e. only visible after careful windowing)) and quantitatively (using relative signal intensity (RSI)). The association of FLAIR hyperintensity with hemorrhage was then tested alongside established predictors (very low cerebral blood volume (VLCBV) and diffusion (DWI) lesion volume) in logistic regression analysis. RESULTS: There were 49 patients with pre-treatment FLAIR imaging (38 received tissue plasminogen activator (tPA), 5 developed PH). FLAIR hyperintensity within the region of acute DWI lesion occurred in 48/49 (98%) patients, was obvious in 18/49 (37%) and subtle in 30/49 (61%). Inter-rater agreement was 92% (κ = 0.82). The prevalence of obvious FLAIR hyperintensity did not differ between studies obtained in the 3-4.5 h and 4.5-6 h time periods (40% vs. 33%, p = 0.77). PH was poorly predicted by obvious FLAIR hyperintensity (sensitivity 40%, specificity 64%, positive predictive value 11%). In univariate logistic regression, VLCBV (p = 0.02) and DWI lesion volume (p = 0.03) predicted PH but FLAIR lesion volume (p = 0.87) and RSI (p = 0.11) did not. In ordinal logistic regression for hemorrhage grade adjusted for age and baseline stroke severity (NIHSS), increased VLCBV (p = 0.002) and DWI lesion volume (p = 0.003) were associated with hemorrhage but FLAIR lesion volume (p = 0.66) and RSI (p = 0.35) were not. CONCLUSIONS: Visible FLAIR hyperintensity is almost universal 3-6 h after stroke onset and did not predict subsequent hemorrhage in this dataset. Our findings question the value of excluding patients with FLAIR hyperintensity from reperfusion therapies. Larger studies are required to clarify what implications FLAIR-positive lesions have for patient selection.
BACKGROUND: Fluid-attenuated inversion recovery (FLAIR) hyperintensity within an acute cerebral infarct may reflect delayed onset time and increased risk of hemorrhage after thrombolysis. Given the important implications for clinical practice, we examined the prevalence of FLAIR hyperintensity in patients 3-6 h from stroke onset and its relationship to parenchymal hematoma (PH). METHODS: Baseline DWI and FLAIR imaging with subsequent hemorrhage detection (ECASS criteria) were prospectively obtained in patients 3-6 h after stroke onset from the pooled EPITHET and DEFUSE trials. FLAIR hyperintensity within the region of the acute DWI lesion was rated qualitatively (dichotomized as visually obvious or subtle (i.e. only visible after careful windowing)) and quantitatively (using relative signal intensity (RSI)). The association of FLAIR hyperintensity with hemorrhage was then tested alongside established predictors (very low cerebral blood volume (VLCBV) and diffusion (DWI) lesion volume) in logistic regression analysis. RESULTS: There were 49 patients with pre-treatment FLAIR imaging (38 received tissue plasminogen activator (tPA), 5 developed PH). FLAIR hyperintensity within the region of acute DWI lesion occurred in 48/49 (98%) patients, was obvious in 18/49 (37%) and subtle in 30/49 (61%). Inter-rater agreement was 92% (κ = 0.82). The prevalence of obvious FLAIR hyperintensity did not differ between studies obtained in the 3-4.5 h and 4.5-6 h time periods (40% vs. 33%, p = 0.77). PH was poorly predicted by obvious FLAIR hyperintensity (sensitivity 40%, specificity 64%, positive predictive value 11%). In univariate logistic regression, VLCBV (p = 0.02) and DWI lesion volume (p = 0.03) predicted PH but FLAIR lesion volume (p = 0.87) and RSI (p = 0.11) did not. In ordinal logistic regression for hemorrhage grade adjusted for age and baseline stroke severity (NIHSS), increased VLCBV (p = 0.002) and DWI lesion volume (p = 0.003) were associated with hemorrhage but FLAIR lesion volume (p = 0.66) and RSI (p = 0.35) were not. CONCLUSIONS: Visible FLAIR hyperintensity is almost universal 3-6 h after stroke onset and did not predict subsequent hemorrhage in this dataset. Our findings question the value of excluding patients with FLAIR hyperintensity from reperfusion therapies. Larger studies are required to clarify what implications FLAIR-positive lesions have for patient selection.
Authors: Bruce C V Campbell; Archana Purushotham; Soren Christensen; Patricia M Desmond; Yoshinari Nagakane; Mark W Parsons; Maarten G Lansberg; Michael Mlynash; Matus Straka; Deidre A De Silva; Jean-Marc Olivot; Roland Bammer; Gregory W Albers; Geoffrey A Donnan; Stephen M Davis Journal: J Cereb Blood Flow Metab Date: 2011-07-20 Impact factor: 6.200
Authors: Gregory W Albers; Vincent N Thijs; Lawrence Wechsler; Stephanie Kemp; Gottfried Schlaug; Elaine Skalabrin; Roland Bammer; Wataru Kakuda; Maarten G Lansberg; Ashfaq Shuaib; William Coplin; Scott Hamilton; Michael Moseley; Michael P Marks Journal: Ann Neurol Date: 2006-11 Impact factor: 10.422
Authors: Bruce C V Campbell; Søren Christensen; Kenneth S Butcher; Ian Gordon; Mark W Parsons; Patricia M Desmond; P Alan Barber; Christopher R Levi; Christopher F Bladin; Deidre A De Silva; Geoffrey A Donnan; Stephen M Davis Journal: Stroke Date: 2009-12-03 Impact factor: 7.914
Authors: Stephen M Davis; Geoffrey A Donnan; Mark W Parsons; Christopher Levi; Kenneth S Butcher; Andre Peeters; P Alan Barber; Christopher Bladin; Deidre A De Silva; Graham Byrnes; Jonathan B Chalk; John N Fink; Thomas E Kimber; David Schultz; Peter J Hand; Judith Frayne; Graeme Hankey; Keith Muir; Richard Gerraty; Brian M Tress; Patricia M Desmond Journal: Lancet Neurol Date: 2008-02-28 Impact factor: 44.182
Authors: Oliver C Singer; Marek C Humpich; Jens Fiehler; Gregory W Albers; Maarten G Lansberg; Andiras Kastrup; Alex Rovira; David S Liebeskind; Achim Gass; Charlotte Rosso; Laurent Derex; Jong S Kim; Tobias Neumann-Haefelin Journal: Ann Neurol Date: 2008-01 Impact factor: 10.422
Authors: Andrew D Barreto; Sheryl Martin-Schild; Hen Hallevi; Miriam M Morales; Anitha T Abraham; Nicole R Gonzales; Kachi Illoh; James C Grotta; Sean I Savitz Journal: Stroke Date: 2009-01-08 Impact factor: 7.914
Authors: Götz Thomalla; Philipp Rossbach; Michael Rosenkranz; Susanne Siemonsen; Anna Krützelmann; Jens Fiehler; Christian Gerloff Journal: Ann Neurol Date: 2009-06 Impact factor: 10.422
Authors: Martin Ebinger; Ivana Galinovic; Michal Rozanski; Peter Brunecker; Matthias Endres; Jochen B Fiebach Journal: Stroke Date: 2009-12-24 Impact factor: 7.914
Authors: Mark Jrj Bouts; Ivo Acw Tiebosch; Umesh S Rudrapatna; Annette van der Toorn; Ona Wu; Rick M Dijkhuizen Journal: J Cereb Blood Flow Metab Date: 2016-01-01 Impact factor: 6.200
Authors: Ruchira Jha; Thomas W K Battey; Ly Pham; Svetlana Lorenzano; Karen L Furie; Kevin N Sheth; W Taylor Kimberly Journal: Stroke Date: 2014-03-11 Impact factor: 7.914
Authors: Caty Carrera; Natalia Cullell; Nuria Torres-Águila; Elena Muiño; Alejandro Bustamante; Antonio Dávalos; Elena López-Cancio; Marc Ribó; Carlos A Molina; Eva Giralt-Steinhauer; Carolina Soriano-Tárraga; Marina Mola-Caminal; Jordi Jiménez-Conde; Jaume Roquer; Cristófol Vives-Bauza; Rosa Díaz Navarro; Victor Obach; Juan Francisco Arenillas; Tomás Segura; Gemma Serrano-Heras; Joan Martí-Fàbregas; Marimar Freijo; Juan Antonio Cabezas; Turgut Tatlisumak; Laura Heitsch; Laura Ibañez; Carlos Cruchaga; Jin-Moo Lee; Daniel Strbian; Joan Montaner; Israel Fernández-Cadenas Journal: Neurology Date: 2019-07-31 Impact factor: 9.910
Authors: Julia Meisterernst; Pascal P Klinger-Gratz; Lars Leidolt; Matthias F Lang; Gerhard Schroth; Pasquale Mordasini; Mirjam R Heldner; Marie-Luise Mono; Rebekka Kurmann; Monika Buehlmann; Urs Fischer; Marcel Arnold; Jan Gralla; Heinrich P Mattle; Marwan El-Koussy; Simon Jung Journal: PLoS One Date: 2017-09-28 Impact factor: 3.240